Pfizer Could Apply for Emergency Use of COVID-19 Vaccine by Late November
Share
[aggregation-styles]
The Wall Street Journal Subscription
Pfizer Inc. laid out a timetable for reaching key milestones in the development of its Covid-19 vaccine that could mean the shots start becoming available in the U.S. before year’s end.
Chief Executive Albert Bourla said Friday the company could start to see from a large study whether the vaccine works by the end of this month and would have data on its safety by the third week of November. If the preliminary results indicate the vaccine can work safely, Pfizer could ask U.S. health regulators to permit use by late November.
Read More →
The Wall Street Journal Subscription
Pfizer Inc. laid out a timetable for reaching key milestones in the development of its Covid-19 vaccine that could mean the shots start becoming available in the U.S. before year’s end.
Chief Executive Albert Bourla said Friday the company could start to see from a large study whether the vaccine works by the end of this month and would have data on its safety by the third week of November. If the preliminary results indicate the vaccine can work safely, Pfizer could ask U.S. health regulators to permit use by late November.
Read More →
RELATED TOPICS:
Categories
Latest
Videos
Politics /
6 hours ago
Trump Says Musk Relationship Over, Warns of ‘Serious Consequences’ if He Funds Democrats
Latest /
7 hours ago
Trump Has Options to Punish Musk Even if His Federal Contracts Continue
Latest /
7 hours ago
Ukrainian Attack Damaged 10% of Russia’s Strategic Bombers, Germany Says
Opinion /
12 hours ago
Why Reforming California’s Bedrock Environmental Law Is Good for the Environment
Sports /
13 hours ago
